Revises law concerning substance use disorder treatment facility patient referrals.
Impact
The most significant change introduced by S3244 is the imposition of a hefty fine of $50,000 for individuals found guilty of violating the referral provisions. This financial penalty is intended to act as a deterrent and indicates the seriousness with which the legislature views the integrity of patient referrals in the context of substance use treatment. By explicitly including health care providers, facilities, and non-profit organizations within its scope, the bill emphasizes the need for accountability at all levels of patient care.
Summary
Senate Bill S3244 aims to amend the existing laws regarding referrals to substance use disorder treatment facilities in New Jersey. The proposed legislation revises the current regulations that criminalize various forms of compensation associated with the referral of patients to treatment facilities. By raising the severity of related offenses from a fourth-degree to a third-degree crime, the bill seeks to provide a stricter legal framework for those involved in the patient referral process, including health care providers and recovery residences.
Contention
Notably, the bill also reflects ongoing concerns about the potential for abuses in patient referrals that could detrimentally affect the quality of care for individuals seeking treatment for substance use disorders. There may be contention regarding the extent of penalties, with some advocating for more lenient measures that encourage collaboration among providers rather than punitive actions that could discourage necessary referrals. This aspect of the bill may result in debates in legislative sessions as stakeholders weigh the balance between regulation and patient access to care.
Establishes Office of Alcohol and Drug Use Disorders Policy to oversee, direct, and coordinate resources, funding, and data tracking concerning treatment of substance use disorders.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.